LGND's Aroon Indicator triggered a bullish signal on November 12, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 259 similar instances where the Aroon Indicator showed a similar pattern. In 214 of the 259 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 83%.
Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where LGND advanced for three days, in 259 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 57 cases where LGND's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LGND as a result. In 66 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for LGND turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 35 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
LGND broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. LGND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.309) is normal, around the industry mean (3.498). P/E Ratio (30.167) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (1.267) is also within normal values, averaging (9.059). Dividend Yield (0.006) settles around the average of (130.981) among similar stocks. P/S Ratio (20.325) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The RSI Indicator for TVTX moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 25 of the 30 cases the stock moved higher. This puts the odds of a move higher at 83%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on TVTX as a result. In 80 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for TVTX just turned positive on October 22, 2026. Looking at past instances where TVTX's MACD turned positive, the stock continued to rise in 37 of 45 cases over the following month. The odds of a continued upward trend are 82%.
Following a +0.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where TVTX advanced for three days, in 213 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TVTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for TVTX entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. TVTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TVTX's P/B Ratio (238.095) is very high in comparison to the industry average of (3.498). P/E Ratio (17.370) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (5.690) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (9.794) is also within normal values, averaging (440.869).
LGND | TVTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 3 | 42 | |
SMR RATING 1..100 | 44 | 99 | |
PRICE GROWTH RATING 1..100 | 39 | 47 | |
P/E GROWTH RATING 1..100 | 95 | 33 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LGND's Valuation (90) in the Biotechnology industry is in the same range as TVTX (100). This means that LGND’s stock grew similarly to TVTX’s over the last 12 months.
LGND's Profit vs Risk Rating (3) in the Biotechnology industry is somewhat better than the same rating for TVTX (42). This means that LGND’s stock grew somewhat faster than TVTX’s over the last 12 months.
LGND's SMR Rating (44) in the Biotechnology industry is somewhat better than the same rating for TVTX (99). This means that LGND’s stock grew somewhat faster than TVTX’s over the last 12 months.
LGND's Price Growth Rating (39) in the Biotechnology industry is in the same range as TVTX (47). This means that LGND’s stock grew similarly to TVTX’s over the last 12 months.
TVTX's P/E Growth Rating (33) in the Biotechnology industry is somewhat better than the same rating for LGND (95). This means that TVTX’s stock grew somewhat faster than LGND’s over the last 12 months.
| LGND | TVTX | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 83% |
| Stochastic ODDS (%) | 1 day ago 72% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 74% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 80% |
| Advances ODDS (%) | 3 days ago 76% | 3 days ago 77% |
| Declines ODDS (%) | 22 days ago 68% | 12 days ago 77% |
| BollingerBands ODDS (%) | 1 day ago 64% | N/A |
| Aroon ODDS (%) | 1 day ago 83% | 1 day ago 80% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LGND’s FA Score shows that 1 FA rating(s) are green while TVTX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LGND’s TA Score shows that 2 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).
LGND (@Biotechnology) experienced а +5.78% price change this week, while TVTX (@Biotechnology) price change was +5.50% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.04%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -16.99%.
LGND is expected to report earnings on Mar 04, 2027.
TVTX is expected to report earnings on Feb 25, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To LGND | 1D Price Change % | ||
|---|---|---|---|---|
| LGND | 100% | -0.18% | ||
| AXON - LGND | 49% Loosely correlated | -2.63% | ||
| ABCL - LGND | 41% Loosely correlated | -2.76% | ||
| TVTX - LGND | 41% Loosely correlated | -0.92% | ||
| VCYT - LGND | 41% Loosely correlated | -1.91% | ||
| TWST - LGND | 38% Loosely correlated | -6.83% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ALRG | 31.35 | 1.07 | +3.53% |
| Allspring LT Large Core ETF (ALRG) | |||
| USMC | 75.62 | 0.14 | +0.19% |
| Principal U.S. Mega-Cap ETF (USMC) | |||
| XMAR | 43.81 | -0.04 | -0.09% |
| FT Vest U.S. Equity Enhance & Moderate Buffer ETF - March (XMAR) | |||
| GVAL | 36.12 | -0.28 | -0.76% |
| Cambria Global Value ETF (GVAL) | |||
| KYLD | 16.99 | -0.19 | -1.11% |
| Kurv High Income ETF | |||